🔴 Pacific Biosciences is trading 6.4% down with no confirmed catalyst

Pacific Biosciences is trading 6.4% lower at $2.18, with no confirmed catalyst identified for the October 12 decline.

• Latest company news located was an October 6 collaboration with TychoBio; it does not establish a reason.
• The CFO’s reported share sale was made under a prearranged Rule 10b5-1 plan, not a clear explanation.
• Shares fell 15.44% on October 8 and rose 1.30% on October 9; October 12 index moves were modest, not enough to explain the decline.